Subsequent mental development of children with lead encephalopathy, as related to type of treatment.
D001921:Brain; D001927:Brain Diseases; D002648:Child; D004112:Dimercaprol / Q000627:therapeutic use*; D004492:Edetic Acid / Q000627:therapeutic use*; D006801:Humans; D007223:Infant; D007855:Lead Poisoning
D004112:Dimercaprol; D004492:Edetic Acid
BRAIN/diseases; DIMERCAPROL/therapeutic use; EDATHAMIL/therapeutic use; LEAD POISONING/in infant and child